全文获取类型
收费全文 | 7271篇 |
免费 | 348篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 149篇 |
儿科学 | 62篇 |
妇产科学 | 82篇 |
基础医学 | 828篇 |
口腔科学 | 154篇 |
临床医学 | 490篇 |
内科学 | 1926篇 |
皮肤病学 | 181篇 |
神经病学 | 396篇 |
特种医学 | 457篇 |
外科学 | 1152篇 |
综合类 | 39篇 |
预防医学 | 282篇 |
眼科学 | 103篇 |
药学 | 628篇 |
中国医学 | 40篇 |
肿瘤学 | 678篇 |
出版年
2023年 | 24篇 |
2022年 | 64篇 |
2021年 | 111篇 |
2020年 | 60篇 |
2019年 | 97篇 |
2018年 | 116篇 |
2017年 | 100篇 |
2016年 | 126篇 |
2015年 | 130篇 |
2014年 | 175篇 |
2013年 | 208篇 |
2012年 | 345篇 |
2011年 | 361篇 |
2010年 | 186篇 |
2009年 | 211篇 |
2008年 | 360篇 |
2007年 | 349篇 |
2006年 | 372篇 |
2005年 | 377篇 |
2004年 | 344篇 |
2003年 | 347篇 |
2002年 | 306篇 |
2001年 | 264篇 |
2000年 | 280篇 |
1999年 | 275篇 |
1998年 | 96篇 |
1997年 | 53篇 |
1996年 | 58篇 |
1995年 | 48篇 |
1994年 | 44篇 |
1993年 | 34篇 |
1992年 | 180篇 |
1991年 | 148篇 |
1990年 | 139篇 |
1989年 | 141篇 |
1988年 | 124篇 |
1987年 | 125篇 |
1986年 | 124篇 |
1985年 | 113篇 |
1984年 | 80篇 |
1983年 | 55篇 |
1981年 | 28篇 |
1979年 | 51篇 |
1977年 | 42篇 |
1975年 | 24篇 |
1974年 | 26篇 |
1971年 | 37篇 |
1969年 | 29篇 |
1968年 | 29篇 |
1967年 | 24篇 |
排序方式: 共有7647条查询结果,搜索用时 921 毫秒
141.
Temocapril treatment ameliorates autoimmune myocarditis associated with enhanced cardiomyocyte thioredoxin expression 总被引:5,自引:0,他引:5
Yuan Z Kishimoto C Shioji K Nakamura H Yodoi J Sasayama S 《Cardiovascular research》2002,55(2):320-328
OBJECTIVE: Thioredoxin (TRX) is a redox regulatory protein that protects cells from various stresses. Angiotensin-converting enzyme (ACE) inhibitor was reported to enhance endogenous antioxidant enzyme activities. This study was carried out to investigate whether temocapril, a novel non-sulfhydryl-containing ACE inhibitor, reduces the severity of myocarditis via redox regulation mechanisms involving TRX. METHODS AND RESULTS: In normal rat myocytes in vitro and in vivo, Western blot showed that temocapril enhanced cytosolic redox regulatory protein TRX expression, but that neither mitochondrial TRX2 nor antioxidant enzymes, such as copper-zinc superoxide dismutase (Cu/Zn-SOD) or manganese superoxide dismutase (Mn-SOD) expression, was up-regulated by the preconditioning treatment. In rats with experimental autoimmune myocarditis (EAM), the severity of myocarditis and the protein carbonyl contents were less increased in temocapril treatment (10 mg/kg/day, orally) from day 1 to day 21, but not in temocapril treatment from day 15 to day 21. An immunohistochemical study showed that TRX stain was enhanced in infiltrating inflammatory cells and in damaged myocytes. Considering the characteristics of this model that myocardial inflammation begins around day 15 and increases until day 21, temocapril treatment for 3 weeks might be thought of as a preconditioning treatment. CONCLUSIONS: The results suggest that TRX and the redox state modified by TRX may play a crucial role in the pathophysiology of EAM. Temocapril ameliorates myocarditis associated with inducing TRX up-regulation in a preconditioning manner, although the mechanism of TRX up-regulation by temocapril remains to be elucidated. 相似文献
142.
Spencer H. Kubo Thomas S. Rector John E. Strobeck Jay N. Cohn 《Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy》1988,2(5):653-660
Summary To characterize the effects of OPC-8212, a quinolone inotropic agent, in patients with heart failure, we utilized invesive homodynamics, exercise testing, 24-hour ambulatory electrocardiograms, and two patient self-assessment questionnaires, before and after 1 month of treatment with OPC-8212, in 17 patients with moderate to severe congestive heart failure. There were no significant changes from baseline in heart rate (83±8 beats/min), mean arterial pressure (70±15 mmHg), pulmonary wedge pressure (18±7 mmHg), or cardiac index (2.3±0.4 L/min/m2) following treatment with OPC-8212. Both exercise duration (5.3±1.6 min) and peak oxygen consumption (12.0±2.9 mL/kg/min) were unchanged by OPC-8212. Two independent patient self-assessment scores, the Sickness Impact Profile and the Minnesota Living with Heart Failure Questionnaire, showed improvements from 6.8 to 5.4 and 49 to 38, respectively (both p<.05), suggesting that the patients reported an improvement in daily functioning. The median ventricular premature contraction count and frequency were reduced from 1,118 beats to 243 beats (p<0.05) and 11/1,000 beats to 2,4/1,000 beats (0.05<p<0.10), respectively. Two patients developed agranulocytosis during longer-term treatment following this 1-month study. These data demonstrate that OPC-8212 did not have significant effects on hemodynamics or exercise tolerance. However, the improvement in patient self-assessment scores and the trend for improvement in ventricular arrhythmia profiles suggest that OPC-8212 may have some benefit for patients with congestive heart failure, but additional placebo-controlled, double-blind studies are necessary. 相似文献
143.
144.
145.
F Ohsuzu S Handa M Kondo H Yamazaki T Tsugu A Kubo Y Takagi Y Nakamura 《Circulation》1980,61(3):620-625
146.
Serum markers of liver fibrosis and histologic severity of fibrosis in resected liver 总被引:5,自引:0,他引:5
Tsukamoto T Yamamoto T Ikebe T Takemura S Shuto T Kubo S Hirohashi K Kinoshita H 《Hepato-gastroenterology》2004,51(57):777-780
BACKGROUND/AIMS: Serum concentrations of the 7S fragment of type IV collagen (7S collagen), amino-terminal propeptide of type III procollagen (PIIIP), and hyaluronic acid (HA) have been reported to serve as serologic markers of liver fibrosis in hepatitis and cirrhosis. We investigated whether these fibrosis markers reliably reflect histologic changes in the livers of patients with hepatocellular carcinoma. METHODOLOGY: Subjects included 165 patients undergoing liver resection for hepatocellular carcinoma. Most were seropositive for chronic hepatitis B or C. Histopathologic changes in liver tissue resected with the tumor were scored according to Knodell's histologic activity index. Serum was sampled for assays shortly before surgery. RESULTS: Significant correlations were found between hepatitis activity score and 7S collagen, PIIIP, and HA. Concentrations of 7S collagen differed significantly between activity grades, but differences were not significant for PIIIP or HA. Significant correlations were found between fibrosis staging score and all these three markers. When patients were divided according to activity grade, 7S collagen showed stronger correlation with fibrosis staging score than did PIIIP or HA. CONCLUSIONS: The 7S collagen fragment correlated more strongly than PIIIP or HA with stage and activity grade in patients with hepatocellular carcinoma. However, overlapping of results between histologically defined groups appeared to limit clinical diagnostic usefulness of all markers in individual patients. 相似文献
147.
Mitsuhashi N Tanaka Y Kubo S Ogawa S Hayashi C Uchino H Shimizu T Watada H Kawasumi M Onuma T Kawamori R 《Endocrine journal》2004,51(6):545-550
The aim of this study was to investigate the effect of cilostazol, a cAMP phosphodiesterase inhibitor, on carotid artery intima-media thickness (IMT) and on the incidence of cardiovascular events in Japanese subjects with type 2 diabetes. A total of 62 type 2 diabetic subjects were allocated equally to the cilostazol treatment group (n = 31) and the control group (n = 31). Carotid IMT was evaluated before and after treatment using B-mode ultrasonography. After the study period (mean +/- SD: 2.6 +/- 0.17 years), carotid IMT showed a significantly greater increase in the control group than in the cilostazol group (0.12 +/- 0.14 mm vs. 0.04 +/- 0.02 mm, p < 0.05). In the control group, 1 out of 31 patients suffered from symptomatic cerebral infarction and 1 had angina pectoris during the observation period. On the other hand, no subject in the cilostazol group developed cardiovascular events during the study period. At baseline, the diabetic patients given cilostazol had a significantly lower HbA1c level than the control subjects, but the other atherosclerotic risk factors (BMI, blood pressure, and serum lipids) and the duration of diabetes did not differ between the two groups. These results indicate that cilostazol therapy can attenuate the increase of carotid artery IMT in Japanese subjects with type 2 diabetes. 相似文献
148.
149.
Yanagi D Shirai K Arimura T Saito N Mitsutake C Mitsutake R Hida S Iwata A Nishikawa H Kawamura A Miura S Saku K 《Internal medicine (Tokyo, Japan)》2008,47(20):1803-1805
We describe the case of an 85-year-old woman in whom pericardiocentesis, prolonged bed rest and blood pressure control were performed without surgery to successfully treat an oozing-type myocardial rupture due to myocardial infarction. 相似文献
150.
Kaneki T Kawashima A Akamatsu T Tanaka N Kubo K Koizumi T Sekiguchi M Hosaka N Honda T Koike S Adachi W 《Journal of gastroenterology》1999,34(2):253-259
We report a rare case of immunoblastic lymphadenopathy (IBL)-like T-cell lymphoma complicated by multiple gastrointestinal
involvement, which appeared to be ameliorated by chemotherapy but resulted in perforative peritonitis. A 66-year-old Japanese
woman who had generalized lymphadenopathy and eruptions was admitted to our hospital because of bloody stool. Colonoscopic
examination revealed hemorrhagic ulcers in the terminal ileum and a saucer-like ulcer in the cecum. Gastrointestinal endoscopy
revealed several ulcerative or elevated lesions in stomach and duodenum. Biopsy specimens of these lesions and of a lymph
node showed characteristic histological features of IBL-like T-cell lymphoma. The initial treatment with prednisolone (PSL)
and cyclophosphamide (CPA) was effective. Six months after the treatment, however, she developed bloody stool again caused
by multiple ulcerative lesions in the large intestine. The recurrence of the disease was determined histologically, and four
courses of CPA, PSL, vinblastine sulfate and doxorubicin hydrochloride (CHOP) therapy were administered. One month after completing
the CHOP therapy, she developed intestinal obstruction and then acute peritonitis resulting from perforation at an ulcer scar
in the jejunum. Surgical treatment was successful, and histological examination demonstrated no lymphoma cells in the resected
specimen. A gastrointestinal perforation should be recognized as a potential complication of IBL-like T-cell lymphoma, even
during remission.
(Received: June 24, 1998; accepted: Oct. 23, 1998) 相似文献